Pine Labs shares surged after the company reported a significant turnaround, posting a Rs 59 crore net profit in Q4FY26 against a loss last year. Full-year profits also swung to Rs 113 crore. Despite a recent share price dip, Morgan Stanley maintains an "Equal-weight" rating with a Rs 245 target, citing strong business growth.